The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep. Studying how insomnia affects PAP adherence in children can help improve future treatments. However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 18
Healthy Volunteers: f
View:

• Children aged 8-18 years old

• Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG)

• Newly prescribed PAP therapy

Locations
Other Locations
Canada
British Columbia Children's Hospital
RECRUITING
Vancouver
Contact Information
Primary
Lena J Xiao, MD MSc
lena.xiao@cw.bc.ca
6048752345
Backup
Macyn LY Leung, MSc
macyn.leung@bcchr.ca
6048752345
Time Frame
Start Date: 2025-06-12
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 82
Treatments
OSA Children Starting PAP
Children aged 8-18 years old diagnosed with obstructive sleep apnea (OSA) who are to be initiated on Positive Airway Pressure (PAP) therapy. Children and their caregivers must be willing and able to complete questionnaires about sleep as well as physical and mental health.
Related Therapeutic Areas
Sponsors
Collaborators: The Hospital for Sick Children (SickKids), American Academy of Sleep Medicine
Leads: Lena Xiao

This content was sourced from clinicaltrials.gov